Nisa Investment Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11K Sell
987
-1,323
-57% -$1.48K ﹤0.01% 2717
2025
Q1
$1.83K Sell
2,310
-14,825
-87% -$11.7K ﹤0.01% 2492
2024
Q4
$28.3K Sell
17,135
-16
-0.1% -$26 ﹤0.01% 1832
2024
Q3
$60K Sell
17,151
-351
-2% -$1.23K ﹤0.01% 1596
2024
Q2
$57.4K Buy
17,502
+365
+2% +$1.2K ﹤0.01% 1625
2024
Q1
$126K Buy
17,137
+297
+2% +$2.18K ﹤0.01% 1410
2023
Q4
$63K Buy
16,840
+15,400
+1,069% +$57.6K ﹤0.01% 1573
2023
Q3
$3.05K Sell
1,440
-109
-7% -$231 ﹤0.01% 2321
2023
Q2
$7.37K Sell
1,549
-3,956
-72% -$18.8K ﹤0.01% 2298
2023
Q1
$31K Buy
5,505
+5,205
+1,735% +$29.3K ﹤0.01% 1861
2022
Q4
$3K Sell
300
-2,162
-88% -$21.6K ﹤0.01% 2336
2022
Q3
$51K Buy
2,462
+362
+17% +$7.5K ﹤0.01% 1731
2022
Q2
$52K Sell
2,100
-260
-11% -$6.44K ﹤0.01% 1717
2022
Q1
$91K Sell
2,360
-180
-7% -$6.94K ﹤0.01% 1647
2021
Q4
$105K Sell
2,540
-360
-12% -$14.9K ﹤0.01% 1499
2021
Q3
$172 Sell
2,900
-200
-6% -$12 ﹤0.01% 1463
2021
Q2
$269 Sell
3,100
-430
-12% -$37 ﹤0.01% 1315
2021
Q1
$291 Sell
3,530
-400
-10% -$33 ﹤0.01% 1354
2020
Q4
$357K Buy
3,930
+1,475
+60% +$134K ﹤0.01% 1267
2020
Q3
$98K Buy
2,455
+1,900
+342% +$75.8K ﹤0.01% 1549
2020
Q2
$19K Buy
555
+30
+6% +$1.03K ﹤0.01% 1784
2020
Q1
$12K Sell
525
-75
-13% -$1.71K ﹤0.01% 1816
2019
Q4
$12K Hold
600
﹤0.01% 1798
2019
Q3
$9K Buy
600
+170
+40% +$2.55K ﹤0.01% 1805
2019
Q2
$9K Hold
430
﹤0.01% 1776
2019
Q1
$8K Hold
430
﹤0.01% 1814
2018
Q4
$6K Hold
430
﹤0.01% 1766
2018
Q3
$7K Buy
+430
New +$7K ﹤0.01% 1805